$281.01-4.73 (-1.66%)
Assurant, Inc.
Assurant, Inc. in the Financial Services sector is trading at $281.01 with a market capitalization of $14.1B. Wall Street consensus targets $330.00 (6 analysts), implying a +17.4% move over the next 12 months. The stock is currently 8% below its 52-week high of $303.94, remaining 14.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.45B↑ | $3.42B↑ | $3.35B↑ | $3.23B↑ | $3.16B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $405.30M↑ | $363.90M↑ | $311.80M↓ | $359.10M↑ | $315.70M |
| Net Income | $298.60M↑ | $274.10M↑ | $225.20M↓ | $265.60M↑ | $235.30M |
Assurant, Inc. provides protection services to connected devices, homes, and automobiles in North America, Latin America, Europe, and the Asia Pacific. It operates through Global Lifestyle and Global Housing segments. The Global Lifestyle segment off...

Here is how Assurant (AIZ) and Hamilton Insurance (HG) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Assurant's embedded protection businesses, technology investments and strong cash generation support recurring growth and higher 2026 earnings expectations.

Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MRSH sees moderate 2027 U.S. pay hikes as AI reshapes compensation planning and Cyber Protect expands its risk services across Asia.
Academic risk and quality models computed from AIZ's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 23.7% reading.
Fama-French 5-factor market beta. The five factors explain 12% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.